Both products, a yoghurt and a yoghurt drink, contain heat deaths Lactobacillus plantarum OLL2712, also known as MI-2 lactic acid bacteria.
A search of the Plusaid FFC database revealed that this is the first time Meiji has launched FFC products containing the strain.
The sugar-free products claim to reduce belly fat in overweight people by suppressing body fat accumulation.
Citing the results of the Japan Management Association Research Institute’s 2020 Health Needs Basic Survey, the Japanese dairy company said more consumers are prioritizing weight management.
“The obesity rate in Japan is increasing, and according to a survey, body fat has become the top health problem for both men and women.
“In addition, due to the ongoing spread of the COVID-19 virus, many people are feeling a lack of exercise as they avoid going out and also because teleworking has increased. As a result, there is a growing awareness of healthy eating to maintain their body shape.” said the company.
The products, which are expected to be priced at JPY143 (US$1) per bottle/cup, would first be launched in convenience stores on October 11.
From November 8th it would be available nationwide via all retail channels.
Consumption of yoghurt with added Lactobacillus plantarum OLL2712 has been shown to significantly reduce abdominal fat area and fasting plasma glucose.
This is according to results published in the scientific journal Current developments in nutritionlast February.
In the study of 100 overweight adults aged 20 to 64, participants were randomized to receive either plain yogurt or yogurt with yogurt Lactobacillus plantarum OLL2712 for 12 weeks.
Until the end of the experiment, they take the yoghurt Lactobacillus plantarum In OLL2712, the total abdominal fat area reduced by approximately 8.5 cm2compared to the placebo group.
Another study published in nutrient in 2020 showed that the intake of Lactobacillus plantarum OLL2712 could lower levels of glycated hemoglobin.
Participants in the randomized, placebo-controlled study have fasting blood glucose levels of 100 to 125 mg/dL and glycated hemoglobin levels in the elevated range of 5.6 to 6.4 percent.
Similarly, they were randomized to receive either conventional yogurt or yogurt containing OLL2712.
While glycated hemoglobin levels were significantly reduced in both groups at the end of the study, the degree of reduction was significantly greater in the intervention group than in the placebo group.
On the other hand, the pro-inflammatory cytokine IL-6 and the highly sensitive c-reactive protein (hsCRP) had increased significantly in the placebo group by the end of the study, but this was not observed in the intervention group.
IL-6 is excreted in large amounts from adipose tissue and is considered a marker for chronic inflammation.
Therefore, the researchers explained that OLL2712 may have controlled glycated hemoglobin levels by preventing chronic inflammation from worsening.
“The main cause of deterioration in glucose metabolism is believed to be chronic inflammation and insulin resistance. Numerous studies have examined the relationship between pro-inflammatory cytokine levels in the blood and metabolic disorders.
“IL-6 secreted by T cells, macrophages and adipocytes plays a key role in the development of insulin resistance and atherosclerosis, pathologies associated with obesity and metabolic syndrome,”they said.